Max Health Q2 Results: Nifty’s latest entrant reports 74% YoY jump in cons PAT to Rs 491 crore, revenue grows 25%

Max Healthcare Institute has announced strong financial results for the September quarter. The company’s net profit surged by 74% year-on-year to Rs 491 crore. Revenue from operations also saw a significant increase of 25% to Rs 2,135 crore. This performance reflects robust growth driven by factors like increased occupied bed days and international patient revenue.

‘Big Short’ fame Michael Burry’s depreciation gripe shines spotlight on big tech profits

Michael Burry has raised concerns that Big Tech’s soaring profits might be artificially inflated due to extended depreciation schedules for computing equipment. While companies like Meta and Alphabet are lengthening asset useful lives, potentially boosting earnings, investors are increasingly scrutinizing the massive capital expenditures on AI infrastructure and the true pace of asset depreciation.

Curis Lifesciences IPO to list today. Check GMP ahead of debut

Curis Lifesciences is set to list on the NSE SME platform on November 14, following an IPO that saw overwhelming investor response, subscribing 74.39 times. The company, which manufactures pharmaceutical formulations, reported strong financial growth in FY25. IPO proceeds will fund facility upgrades, working capital, and market expansion.

PhysicsWallah IPO allotment today: Here’s how to check your status, GMP and what to expect from listing

PhysicsWallah’s Rs 3,480 crore IPO, one of the largest in Indian edtech, is set to finalize allotment on Friday with moderate subscription and a 0% grey market premium, indicating a cautious listing. The company, known for its hybrid model and diverse courses, reported strong revenue growth but remains loss-making, with IPO funds earmarked for offline expansion and technology investments.

Tata Steel shares in focus after Q2 PAT surges fourfold to Rs 3,183 crore

Tata Steel’s September quarter profit soared fourfold to Rs 3,183 crore, driven by robust Indian sales and improved Netherlands operations. Consolidated sales climbed nearly 9% to Rs 58,689 crore, with Ebitda jumping 46%. The company also saw a reduction in UK operating losses and a decrease in tax expenses, signaling a strong financial performance.